Ompekimig
Ompekimig is an immunoglobulin monoclonal antibody that targets IL-4, IL-13, IL-33. Ompekimig shows potential for use in immune-mediated inflammatory diseases such as asthma and atopic dermatitis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 2981477-39-6
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Isotype
immunoglobulin (L-kappa-H-gamma1(_L-VH-G1(CH1-h))_L-kappa)_( H-gamma1_L-kappa)
Recommend Isotype Controls
Species Reactivity
Human
IC50 & Target
[1]|
IL-4 |
IL-13 |
IL-33 |
体外実験
Ompekimig is an antibody against hIL-4, hIL-13, and hIL-33[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
遺伝子ID
アクセッション番号
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Fab-kappa_IgG1-kappa_disulfide
アプリケーション
ELISA, FACS, Functional assay
化学情報
-
CAS 番号 2981477-39-6
-
SMILES
N/A
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
プロトコル
-
TPA/Croton Oil Ear Edema and Dermatitis
The TPA (12-O-tetradecanoylphorbol-13-acetate) and croton oil-induced mouse ear edema model is a well-established acute cutaneous inflammation system used to evaluate topical anti-inflammatory activity by measuring edema formation, neutrophil infiltration, vascular permeability, and cytokine-mediated skin responses in vivo. The inflammatory response is triggered by topical application of phorbol esters (TPA) or croton oil constituents, leading to rapid activation of protein kinase C signaling, leukocyte recruitment, and increased vascular permeability, which can be quantified by ear thickness, weight, dye extravasation, and biochemical markers such as myeloperoxidase (MPO) activity and pro-inflammatory mediators in ear tissue homogenates. This model is widely used for screening anti-inflammatory agents, where reductions in edema and inflammatory biomarkers reflect suppression of acute dermal inflammation and immune cell infiltration. Histological evaluation typically confirms epidermal
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)
Keywords
- Ompekimig
- 2981477-39-6
- Interleukin Related
- heavy chain amino acid sequences
- light chain amino acid sequences
- N-terminal glutaminyl cyclization
- fucosylated complex bi-antennary CHO-type N-glycosylation
- disulfide bridges
- post-translational modifications
- monoclonal antibody
- C-terminal lysine clipping
- N-terminal cyclization
- N-glycosylation
- Inhibitor
- inhibitor
- inhibit